The LEADLESS Observational Study

NCT02051972 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 491

Last updated 2025-06-06

Study results available
· View outcomes & findings →

Summary

The objective of the study is to confirm clinical performance and safety of the Nanostim leadless cardiac pacemaker system within its intended use and according to its instructions for use.

Conditions

  • Indications for VVI(R) Pacemaker

Interventions

DEVICE

Implanted with a Nanostim leadless pacemaker system

Sponsors & Collaborators

  • Abbott Medical Devices

    lead INDUSTRY

Principal Investigators

  • Johannes Sperzel, MD · Kerckhoff Klinick GmbH, Bad Nauheim, Germany

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-12-31
Primary Completion
2017-03-31
Completion
2021-12-22

Countries

  • Czechia
  • France
  • Germany
  • Italy
  • Netherlands
  • Spain
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02051972 on ClinicalTrials.gov